JPRN-UMIN000002447SuspendedPhase 2
Study of neoadjuvant Letrozole combined with standerd chemotherapy for postmenopausal women with Endocrine-responsive Breast Cancer(subject of stage2,3A) - Niigata Breast Cancer Trial-02
iigata Cancer Center Hospital0 sites80 target enrollmentStarted: September 4, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Suspended
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 60years-old to 70years-old (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Serious complications ( e.g malignant hypertension, CHF, hepatic failure, MI within 6 months, PE, arrhythmia treatment needed, infection, hemorrhagic tendency ) 2.Hepatitis B 3.Serious Diabetes mellitus 4.Infection disease 5.Active multiple cancer 6.Edema 7.Inflammatory breast cancer 8.Synchronous bilateral breast cancer 9.History of drug-hypersensitivity 10.Patients have been treated with steroid or hormone replacement therapy or raloxifene 11.Mental disease 12.Osteoporosis, treated with bisphosphonate at present 13.Patient judged inappropriate for this study by the physicians
Investigators
Similar Trials
Completed
Phase 2
Evaluation of efficacy of letrozole as a neoadjuvant endocrine therapy in postmenopausal patients with hormone receptor-positive breast cancerBreast cancerJPRN-UMIN000003101Tohoku University Graduate School of Medicine30
Recruiting
Phase 3
Evaluation of the effect of hormone therapy in breast cancer before surgeryBreast cancer.Malignant neoplasm of breast, endocrine therapy, neoadjuvantIRCT20181224042091N1Mashhad University of Medical Sciences48
Completed
Phase 3
Adjuvant Therapy for Postmenopausal Patients with Operable Breast Cancer who have Estrogen Receptor or Progesterone Receptor Positive Tumors.Tamoxifen vs. Letrozole vs. Tamoxifen followed by Letrozole vs. Letrozole followed by TamoxifeBreast CancerACTRN12607000012471ovartis Pharma AG, Basel6,193
Recruiting
Not Applicable
The effect of letrozole on treatment of endometriosis-related infertilityIRCT20150310021420N4Tehran University of Medical Sciences144
Completed
Not Applicable
A Phase III Study to Evaluate Letrozole as Adjuvant Endocrina Therapy for Postmenopausal Women with Receptor (ER and/or PgR) Positive Tumors-C509 Breast, unspecifiedBreast, unspecifiedC509PER-051-00OVARTIS BIOSCIENSES PERU S.A.,